Schematic depicting the involvement of regional sympathetic nerves in the mediation of pain in early-stage TMJ-OA. GA, UNITED STATES, Febru ...

In patient-derived and animal tumour models, mubritinib suppressed glioblastoma stem cells and tumour growth by targeting ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an 710032, ...

A postnatal neural stem cell (NSC) in the ventricular-subventricular zone. The majority of postnatal NSCs are maintained in a quiescent state, allowing for long-term maintenance. Birth-induced ...

Mesenchymal stem cells (MSC) offer immense potential in upgrading treatments for serious medical conditions. Credit: via Shutterstock. As cell and gene therapies become more prevalent, the need for ...

These solidlike knots, called amyloids, can be toxic to cells and kill off neural tissue. Some researchers suspect that such problematic protein aggregates might arise from improper control of ...

They found that the treatment reversed brain hyperexcitability in rats with strokes, restoring balance in neural networks ... Modified human mesenchymal stromal/stem cells restore cortical ...

This study presents an important application of high-content image-based morphological profiling to quantitatively and systematically characterize induced pluripotent stem cell-derived mixed neural ...

They found that the treatment reversed brain hyperexcitability in rats with strokes, restoring balance in neural networks ... “Modified human mesenchymal stromal/stem cells restore cortical ...

The neural crest is an essential part of the embryo, and this region of cells forms the bones of our face and neck, as well as parts of the nervous system. Dr. Barriga and colleagues found that ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...